medicexum
InsightsRegulation · Quality · Market

Field notes from inside UK medicinal cannabis & CBD.

Practical regulatory analysis, quality benchmarks and commercial reads — written for founders, operators and investors who need to act on what they read, not just file it away.

Featured·Compliance
2025 · 02 · 8 min
Medicexum / Field Notes

How to Become a Responsible Person (RP) in the UK Medical Cannabis Industry

A step-by-step guide to qualifying as a Responsible Person under MHRA and GDP — covering training, licensing and the operational expectations regulators look for.

Read the full piece
MHRA UpdatesFSA Novel FoodsEU GMPICH Q1ABritish PharmacopoeiaHome OfficeACMDACNFPMHRA UpdatesFSA Novel FoodsEU GMPICH Q1ABritish PharmacopoeiaHome OfficeACMDACNFPMHRA UpdatesFSA Novel FoodsEU GMPICH Q1ABritish PharmacopoeiaHome OfficeACMDACNFP
Latest

More from the desk.

Industry2025 · 02

How Media Bias is Holding Back the Cannabis Industry

Why public perception remains a hurdle for medicinal cannabis — and what operators can do to counter outdated narratives in the press.

5 min
Regulation2025 · 02

The Importance of MHRA Compliance for UK Medical Cannabis Brands

Scrutiny of medicinal cannabis advertising and promotion is rising. Compliance with MHRA's Blue Guide is now a commercial differentiator.

6 min
Market2025 · 02

The Global Cannabis Market 2024: Key Insights & Trends

Legalisation, market expansion and patient access — the global picture and what it means for UK operators and investors.

7 min
Investment2025 · 02

Why Now is the Best Time to Invest in the UK Medical Cannabis Market

Rapid growth, regulatory clarity and investor appetite are converging — a practical look at where capital is flowing in UK medical cannabis.

6 min
Quality2025 · 02

UK Medical Cannabis Stability Testing: ICH Guidelines & Compliance

Stability studies, ICH alignment and British Pharmacopoeia obligations — what UK medical cannabis operators must demonstrate to stay compliant.

7 min
Briefing

Get our regulatory & commercial briefings before they're public.

Short, signal-only updates for founders, boards and investors operating in UK medicinal cannabis and CBD novel foods.

Request the briefing